Active, Not Recruiting
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
NCT06248619
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
- Advanced Quality Medical Research Orland Park, Illinois, United States
- W Kellogg Eye Center Ann Arbor, Michigan, United States
- Las Vegas Endocrinology Henderson, Nevada, United States